- Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing
-
Rehman R, Riaz MS, Esharif D, Has P, Herzlinger M, Shapiro J, Subedi S
- KMID: 2558194
- Intest Res.
- 2024 Jul;22(3):351-356.
- doi: 10.5217/ir.2023.00091
Background/Aims: To describe the role of ustekinumab in inducing remission and endoscopic healing in anti-tumor necrosis factor α nonresponsive pediatric ulcerative colitis patients at a tertiary care inflammatory bowel disease... -
- CITED
-
- Close
- SHARE
-
- Close
